Announcements Trials
Browse Landscape

Phase

Phase 2 2Phase 4 1Phase 3 1

Status

Completed 2Withdrawn 1Unknown 1

Sponsor Class

OTHER 2NETWORK 1INDUSTRY 1

Study Type

Interventional 4Observational 1

Sponsor

Cancer Type

CNS 7Breast 4Sarcoma 3Tumor-Agnostic 2Gastrointestinal 2Thoracic 1Other neoplasm 1Lymphoid 1Gynecologic 1Genitourinary 1

Conditions

Breast Neoplasms 4

Interventions

Trastuzumab 696Paclitaxel 679Cyclophosphamide 634Docetaxel 554Capecitabine 468Letrozole 407Carboplatin 393Fulvestrant 379Doxorubicin 330Tamoxifen 288pembrolizumab 272Anastrozole 252Epirubicin 249exemestane 238pertuzumab 229Bevacizumab 214Radiotherapy 213Gemcitabine 211Vinorelbine 188palbociclib 183Lapatinib 175130-nm albumin-bound paclitaxel 168Albumin-Bound Paclitaxel 156Exercise 147Magnetic Resonance Spectroscopy 145eribulin 144Taxes 134Fluorouracil 131Everolimus 118Cisplatin 118

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

4 trials
RecentStart dateEnrollment
Interventional × Gadolinium DTPA × Breast × Clear all
NCT00373152 2017-12-05

MRI in Predicting Tumor Reponse After Radiofrequency Ablation in Women With Invasive Breast Cancer

Masonic Cancer Center, University of Minnesota

Phase 2 Withdrawn
Breast

Breast Neoplasms

NCT01956409 2016-02-04

Proton MR Spectroscopy and 18F-Fluorocholine PET for Breast Cancer Diagnosis

National Taiwan University Hospital

Phase 4 Unknown
80 enrolled
Breast

Breast Neoplasms

NCT00043017 2013-10-09

ACRIN 6657

American College of Radiology Imaging Network

Phase 2 Completed
356 enrolled
Breast

Breast Neoplasms

NCT00486473 2010-07-15

DETECT

Bracco Diagnostics, Inc

Phase 3 Completed
130 enrolled
Breast

Breast Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡